According to Marinus Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -ยฃ0.08494. In 2022 the company made an earnings per share (EPS) of -ยฃ0.32 an increase over its 2021 EPS that were of -ยฃ2.08.
Year | EPS | Change |
---|---|---|
2023 (TTM) | ยฃ0.07528 | -123.78% |
2022 | -ยฃ0.32 | -84.76% |
2021 | -ยฃ2.08 | -9.12% |
2020 | -ยฃ2.29 | -25.81% |
2019 | -ยฃ3.08 | 10.83% |
2018 | -ยฃ2.78 | 9.76% |
2017 | -ยฃ2.53 | -44.22% |
2016 | -ยฃ4.54 | -12.5% |
2015 | -ยฃ5.19 | 34.49% |
2014 | -ยฃ3.86 | 11.01% |
2013 | -ยฃ3.48 |